Your weekly roundup of the latest news from Drug Topics®.
The FDA has issued a 1-year delay on the final enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA) that were set to take effect in November.
Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.
Legal challenges have made dispensing abortion medications more difficult than ever.
Preventative cancer screenings have added millions of years to the lives of Americans and have saved the United States economy trillions of dollars, according to recent research published in the journal BMC Health Services Research.
The FDA has approved Pfizer’s bivalent respiratory syncytial virus (RSV) vaccine (Abrysvo) for use during pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months.